14 May 2020PatentsRory O'Neill

Federal Circuit extends Arthrex ruling to reexaminations

The US Court of Appeals for the Federal Circuit’s controversial Arthrex decision applies to the old inter partes reexamination system, the court has clarified, in a blow for technology company Cisco.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Patents

Fewer bites at the IPR apple now possible

29 May 2020 Evan Day and Olivia Nguyen of Perkins Coie outline the Patent Trial and Appeal Board’s tougher stance relating to serial inter partes review petitions.

Patents

Arthrex: who are you calling inferior?

3 November 2020 In October, the US Supreme Court agreed to hear Arthrex v Smith & Nephew. Jason Romrell, Derek McCorquindale, and Brandon Andersen of Finnegan, Henderson, Farabow, Garrett & Dunner, outline what this means.

Patents

Federal Circuit refuses Arthrex rerun, prerogative now with SCOTUS

24 March 2020 The US Court of Appeals for the Federal Circuit will leave it to the Supreme Court to review its controversial Arthrex decision that Patent Trial and Appeal Board judges were unconstitutionally appointed.

DexCom suffers second patent revocation at hands of UPC

Q&A: Counsel on leading Paltalk’s $65.7m win against Cisco

Plastic evolution: how Lego is using IP to build a more sustainable brand

INTA sounds warning to SCOTUS over corporate liability case

‘You need a lot of time’: Bardehle Pagenberg's Tilman Müller on the UPC

How an Academy Award-winning makeup pro helped win rare $30.5m beauty trial

The Tunisian women leveraging IP to protect their art and heritage

EU Commission report: ‘All member states’ should join UPC

Federal Circuit extends Arthrex ruling to reexaminations

More on this story

Editor's picks

Editor's picks

More articles